ÂÜÀòÂÒÂ×

Sander van Deventer is Professor of Experimental Medicine at the Academic Medical Center in Amsterdam and general partner of Forbion Capital Partners (formerly, ABN AMRO Capital). Dr. van Deventer has held numerous academic appointments and has been the principle clinical investigator for several clinical trials. He has served on a number of regulatory and pharmaceutical industry scientific advisory boards and has been an advisor to the Food and Drug Administration. Dr. van Deventer received his M.D. and Ph.D. from the University of Amsterdam.